Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis
暂无分享,去创建一个
Dong Soo Lee | June-Key Chung | Kyoungjune Pak | Keon Wook Kang | Gi Jeong Cheon | Seong-Jang Kim | Kyoungjune Pak | Seong-Jang Kim | G. Cheon | D. Lee | K. Kang | E. Kim | June-Key Chung | E. Edmund Kim | Hyun-Yeol Nam | Hyun-Yeol Nam
[1] Xiaomin Li,et al. Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma , 2010, Acta oto-laryngologica.
[2] Su Jin Lee,et al. Prognostic Value of Volume-Based 18F-Fluorodeoxyglucose PET/CT Parameters in Patients with Clinically Node-Negative Oral Tongue Squamous Cell Carcinoma , 2012, Korean journal of radiology.
[3] Ngan-Ming Tsang,et al. Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma , 2012, The Journal of Nuclear Medicine.
[4] Xiao-dong Zhu,et al. Accuracy of whole‐body PET and PET‐CT in initial M staging of head and neck cancer: A meta‐analysis , 2011, Head & neck.
[5] L. Kong,et al. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma , 2010, Journal of Cancer Research and Clinical Oncology.
[6] S. Yang,et al. Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[7] T. Miller,et al. Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[8] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[9] W. Sauerbrei,et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.
[10] Qianying Zhao,et al. Prognostic Value of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography or PET-Computed Tomography in Cervical Cancer: A Meta-Analysis , 2013, International Journal of Gynecologic Cancer.
[11] R. Subramaniam,et al. PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma. , 2013, AJR. American journal of roentgenology.
[12] S. Hyun,et al. Prognostic Significance of Volume-Based PET Parameters in Cancer Patients , 2012, Korean journal of radiology.
[13] L. Quekel,et al. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. , 2009, AJR. American journal of roentgenology.
[14] Jeong Hyun Lee,et al. Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis Measured by 18F-FDG PET/CT in Salivary Gland Carcinomas , 2013, The Journal of Nuclear Medicine.
[15] Shixi Liu,et al. 18FDG PET and PET‐CT for the detection of bone metastases in patients with head and neck cancer. A meta‐analysis , 2013, Journal of medical imaging and radiation oncology.
[16] S. Kannan,et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[17] Jeon Yeob Jang,et al. Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer , 2009, Clinical Cancer Research.
[18] Chun-Ta Liao,et al. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma. , 2013, Oral oncology.
[19] Yongkui Lu,et al. 18FDG-PET/CT for the detection of regional nodal metastasis in patients with primary head and neck cancer before treatment: a meta-analysis. , 2013, Surgical oncology.
[20] Dong Soo Lee,et al. Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology , 2014, Nuclear Medicine and Molecular Imaging.
[21] J. Roh,et al. Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] Peter Smeets,et al. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[23] C. McConkey,et al. A systematic review and meta‐analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[24] H. Quon,et al. FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. , 2012, Imaging in medicine.
[25] Rathan M. Subramaniam,et al. 18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging , 2012, The Journal of Nuclear Medicine.
[26] N. Lee,et al. 18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma , 2012, The Journal of Nuclear Medicine.
[27] T. Yen,et al. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification , 2011, Nuclear medicine communications.
[28] T. Turkington,et al. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. , 2012, International journal of radiation oncology, biology, physics.
[29] Stefan Michiels,et al. Meta-analysis when only the median survival times are known: A comparison with individual patient data results , 2005, International Journal of Technology Assessment in Health Care.
[30] H. Jang,et al. FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer , 2011, Radiation oncology journal.
[31] Guo-zeng Xu,et al. Comparison of whole body positron emission tomography (PET)/PET‐computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: A meta‐analysis , 2012, The Laryngoscope.
[32] W. Thorstad,et al. Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma , 2013, Journal of Radiation Oncology.
[33] Shu-qi Wu,et al. Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis , 2009, European journal of gastroenterology & hepatology.
[34] Jinming Yu,et al. 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis , 2011, Journal of Cancer Research and Clinical Oncology.
[35] John P A Ioannidis,et al. F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma: A Meta-analysis , 2008 .
[36] M. Parmar,et al. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.